Clinical Trial Detail

NCT ID NCT03181308
Title Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Tracon Pharmaceuticals Inc.
Indications

lung non-small cell carcinoma

Therapies

Carotuximab + Nivolumab

Age Groups: adult senior

Additional content available in CKB BOOST